Old Dominion Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$367K Hold
3,406
0.08% 139
2021
Q2
$384K Sell
3,406
-118
-3% -$13.3K 0.08% 134
2021
Q1
$381K Sell
3,524
-262
-7% -$28K 0.09% 131
2020
Q4
$406K Buy
3,786
+118
+3% +$11.3K 0.1% 121
2020
Q3
$321K Hold
3,668
0.09% 122
2020
Q2
$360K Hold
3,668
0.11% 115
2020
Q1
$279K Hold
3,668
0.12% 118
2019
Q4
$325K Sell
3,668
-584
-14% -$48.5K 0.11% 125
2019
Q3
$322K Buy
4,252
+184
+5% +$12.6K 0.11% 120
2019
Q2
$296K Sell
4,068
-700
-15% -$55K 0.1% 116
2019
Q1
$375K Sell
4,768
-250
-5% -$20.5K 0.13% 111
2018
Q4
$463K Hold
5,018
0.17% 110
2018
Q3
$475K Buy
+5,018
New +$476K 0.14% 114

Other funds holding ABBV

Old Dominion Capital Management's ABBV Position: Q3 2021 in Review

Old Dominion Capital Management held its AbbVie (ABBV) position steady in Q3 2021 at 3,406 shares worth $367K. The position accounts for 0.08% of the portfolio, ranked #139.

Old Dominion Capital Management first reported a position in ABBV in Q3 2018 and has held it in 13 quarters since. The position peaked at $475K in Q3 2018. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Old Dominion Capital Management held 3,406 shares of AbbVie worth $367K as of Q3 2021.
  • Old Dominion Capital Management left its AbbVie share count unchanged in Q3 2021.
  • AbbVie made up 0.08% of Old Dominion Capital Management's portfolio in Q3 2021, its #139 holding.
  • Old Dominion Capital Management first reported a position in AbbVie in Q3 2018 and has held it in 13 quarters since.
  • Old Dominion Capital Management's AbbVie position peaked at $475K in Q3 2018.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.